Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus structural proteins VP4 and VP7 are the primary components of the virus's outer capsid and serve as the critical determinants of viral infectivity and host range. VP4 is a non-glycosylated, protease-sensitive spike protein that mediates attachment to host cell receptors, such as sialic acids or integrins, and undergoes trypsin cleavage to facilitate membrane penetration [1.2.2, 1.3.1]. VP7 is a calcium-dependent glycoprotein that forms the outer shell of the virion and is essential for stabilizing the capsid and mediating cell entry [1.3.3, 1.4.1]. Together, these proteins define the G (VP7) and P (VP4) serotypes, which are the basis for rotavirus classification and the primary targets for neutralizing antibodies [1.2.1, 1.2.5]. Therapeutic strategies primarily involve live-attenuated vaccines like Rotarix and RotaTeq, which induce protective immunity against these antigens to prevent severe gastroenteritis in infants [1.1.1, 1.1.2]. Emerging research also investigates monoclonal antibodies and small-molecule inhibitors designed to block the attachment and uncoating processes mediated by these proteins [1.3.1, 1.3.3].
Induction of neutralizing antibodies that bind to VP4 and VP7, preventing viral attachment to host receptors and inhibiting the uncoating process required for cell entry [1.1.1, 1.3.3].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus structural proteins VP4 and VP7 (VP4/VP7).